-
- Description: IGI, Inc. is engaged in the production and marketing of cosmetics and skin care products. The Company is focused on the commercialization of the Novasome lipid vesicle encapsulation and other microencapsulation technologies for skincare applications. The Company has a 10-year license to use the Novasome in the fields of animal pharmaceuticals, biologicals and other animal health products; foods, food applications, nutrients and flavorings; cosmetics, consumer products and dermatological over-the-counter and prescription products (excluding certain topically delivered hormones); fragrances, and chemicals, including herbicides, insecticides, pesticides, paints and coatings, photographic chemicals and other specialty chemicals, and the processes for making the same. In May 2002, the Company sold its pet business to Vetoquinol N. A. Inc., the North American subsidiary of the Vetoquinol Group. Igi, Inc., manufactures creams, liquids, and other topical products for drug and cosmetics companies using its microencapsulation technology. It originally licensed the technology, dubbed Novasome, from drug firm Novovax. The Novasome process entraps and protects the active ingredients of various skin care products, moisturizers, shampoos, and fragrances, allowing for greater stability during storage and a more controlled release when used. The company is examining further applications of the Novasome technology in food, personal care products, and pharmaceuticals.
- More Products No Keyword available...
- About Owner No Owner Type Present...
-
